glp-1 agonists medications list How are transforming diabetes and weight loss treatment GLP-1 Agonists: A Comprehensive Overview

(NYSE: ABBV), Viking Therapeutics Inc

Lancet 2009;373:473481

Review findings The review confirms that incretin-based therapies have not only achieved their intended goal of T2D and obesity management but have also demonstrated clinically meaningful benefits across multiple organ systems

J Int Med Res

But with that influx comes headaches for the patients seeking the drugs, and the physicians who prescribe them

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage